Valuation Torrent Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. 14:22:07 01/10/2026 +04			5-day change	1st Jan Change
4,761.95 ^INR	-0.82%		-3.51%	+23.95%

09-28	Torrent Pharma to Pay More for its 26% Stake in Power Unit After Amending Agreement	MT
09-08	India's Torrent Gas files updated IPO papers	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	473,197	520,309	880,347	1,094,736	1,428,460	1,811,293	-	-
Change	-	9.96%	69.2%	24.35%	30.48%	26.8%	-	-
Enterprise Value (EV) ¹	508,027	566,719	910,767	1,119,846	1,564,790	1,933,296	1,904,894	1,869,352
Change	-	11.55%	60.71%	22.96%	39.73%	23.55%	-1.47%	-1.87%
P/E	60.9x	57.4x	53.1x	57.3x	66x	70.7x	51.2x	41.2x
PBR	7.95x	8.4x	12.8x	14.4x	17x	12.7x	10.9x	9.36x
PEG	-	3.4x	0.6x	3.7x	5x	13.25x	1.3x	1.7x
Capitalization / Revenue	5.56x	5.41x	8.21x	9.51x	10.2x	9.15x	8.13x	7.26x
EV / Revenue	5.97x	5.89x	8.49x	9.72x	11.2x	9.76x	8.55x	7.49x
EV / EBITDA	20.9x	19.9x	27x	30.1x	34.3x	29x	24.5x	21x
EV / EBIT	28.7x	26.5x	34.4x	38.3x	45.5x	44.2x	35.2x	28.9x
EV / FCF	31.8x	31.6x	32.1x	56.7x	66.7x	49.2x	34.9x	30.9x
FCF Yield	3.15%	3.17%	3.11%	1.76%	1.5%	2.03%	2.86%	3.24%
Dividend per Share ²	16.5	22	28	32	38	32.7	38.18	46.78
Rate of return	1.18%	1.43%	1.08%	0.99%	0.9%	0.69%	0.8%	0.98%
EPS ²	22.96	26.79	48.94	56.47	63.92	67.33	92.92	115.4
Distribution rate	71.8%	82.1%	57.2%	56.7%	59.4%	48.6%	41.1%	40.5%
Net sales ¹	85,080	96,200	107,280	115,160	139,800	198,060	222,820	249,657
EBITDA ¹	24,310	28,420	33,680	37,210	45,590	66,600	77,800	89,023
EBIT ¹	17,690	21,350	26,480	29,260	34,400	43,718	54,154	64,773
Net income ¹	7,770	12,450	16,560	19,110	21,630	24,722	34,254	43,639
Net Debt ¹	34,830	46,410	30,420	25,110	136,330	122,003	93,601	58,060
Reference price ²	1,398.15	1,537.35	2,601.15	3,234.60	4,220.65	4,761.95	4,761.95	4,761.95
Nbr of stocks (in thousands)	338,445	338,445	338,445	338,445	338,445	380,368	-	-
Announcement Date	25/05/22	30/05/23	24/05/24	20/05/25	22/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TORRENT PHARMACEUTICALS LIMITED	70.73x	9.76x	29.03x	0.69%	18.81B
ELI LILLY AND COMPANY	32.69x	11.85x	24.08x	0.6%	1,025B
JOHNSON & JOHNSON	28.77x	6.4x	17.91x	2.06%	623B
ABBVIE INC.	32.89x	7.71x	15.93x	2.67%	459B
MERCK & CO., INC.	104.62x	5.85x	24.82x	2.37%	355B
ROCHE HOLDING AG	18.99x	4.63x	11.47x	2.87%	336B
NOVARTIS AG	20.13x	5.23x	12.95x	3.06%	270B
ASTRAZENECA PLC	20.27x	4.21x	12x	2.1%	247B
AMGEN INC.	25.72x	6.72x	11.97x	2.48%	220B
GILEAD SCIENCES, INC.	-44.61x	6.5x	25.4x	2.23%	183B
Average	31.02x	6.89x	18.55x	2.11%	373.7B
Weighted average by Cap.	31.93x	7.66x	18.76x	1.94%